Navigation Links
HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
Date:12/14/2007

Settlement Resolves Investigation of Physician Kickbacks

WASHINGTON, Dec. 14 /PRNewswire-USNewswire/ --- HealthSouth Corporation and two physicians have agreed to pay the United States a total of $14.9 million to settle allegations that the Birmingham, Ala.-based company submitted false claims to the government and paid illegal kickbacks to physicians who referred patients for care in some of its hospitals, outpatient rehabilitation clinics, and ambulatory surgery centers, the Justice Department announced today.

HealthSouth will pay $14.2 million, and the physicians will pay a total of $700,000 under separate settlement agreements. HealthSouth, currently the nation's largest provider of inpatient rehabilitation services, was also one of the largest providers of outpatient rehabilitation services, ambulatory surgery services, and diagnostic imaging services until it sold those lines of business earlier this year.

Today's settlement results from disclosures made by HealthSouth in 2004 and 2005 to the U.S. Attorney for the Northern District of Alabama, Alice Martin, and the Department of Health and Human Services' Office of Inspector General, after a change in management and an internal investigation. The government's investigation was jointly handled by the U.S. Attorney's Office for the Northern District of Alabama, the U.S. Attorney's Office for the Central District of California, the Civil Division of the Department of Justice, the Department of Health and Human Services, Office of Inspector General, and the FBI.

The settlement resolves claims made by HealthSouth to Medicare and Medicaid for services provided to patients referred by orthopedic surgeons Drs. James Andrews and Lawrence Lemak of Birmingham, when HealthSouth had financial relationships with the physicians, their former partnership, the Alabama Sports Medicine and Orthopaedic Clinic, and their research and training foundation, the American Sports Medicine Insti
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Corporation Appoints New Member to Board of Directors
3. HealthSouth Announces Date of Third Quarter Earnings Conference Call
4. Broad-based group of physicians calls for improvement in stroke treatment
5. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
6. Psychiatrists are the least religious of all physicians
7. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
8. Scientists, physicians present latest findings in personalized cancer treatment and prevention
9. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
10. U.S. Physicians Question Presidential Candidates
11. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...linical trial results could lead to availability o...eatment for deep lines and wrinkles by 2009. , ... 24, 2008 -- Gel-Del Technologies , a St. Paul, M... that it has concluded clinical trials of CosmetaL...als say holds potential to be a more effective alt...
(Date:7/24/2008)...ll/ --, Key Highlights, Misys plc (LSE: MSY) del...sing targets for the next phase of the turnaround....%, bringing Group operating profit(2) to GBP81m,3...trategy and entering,into the next phase of the tu...o view the Multimedia News Release, please click:,...
(Date:7/23/2008)...wire/ -- MediVoice(R), LLC, the,world,s first mobi...escribing, has formed a strategic partnership with... web-based, patient-centered health record,managem...e and market its,mobile voice-activation solution ...., "MediVoice is pleased to develop a strategic p...
(Date:7/23/2008)..., July 23 /PRNewswire-FirstCall/ - Cardiome Pharma...t it has entered into an,agreement with CR Intrins...,CR Intrinsic Investors, LLC, an affiliate of S.A....ertible preferred shares for gross proceeds of,US$... for general corporate,purposes, costs associated ...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 2Health News:MediVoice(R) Partners With VisionTree(R) to Integrate Its Voice-Activated e-Prescribing Solution Into VisionTree's VTOC(TM) Web-Based Patient Management System 3Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3
...ndia has declined over the century from 972 in 190... to 933 in 2001. In contrast, the child sex rati...rls per thousand boys against 945 recorded in 1991...tio is concerned, it is 1.01 male (s)/females as i...
...ntessentially Indian puff, has become a victim of ...outhern districts of Tamil Nadu going on strike. ...wrapped in leaf, from Tirunelveli, Tuticorin and K...this weekend to protest the union health ministry ...
...Democratic Front (LDF) government, set to mark its...at it is to blame for the deaths of 38 newborns in...fection in the labour room of the Sree Avittam Tir...the last two months. A court has charged Health M...
...is of concern as it is a reflection of the prevale...s and the extent of transmission of TB infection ...orted under the programme are of paediatric age gr...ntage of paediatric cases reported at national lev...
Other Medicine News:Health News:Bidi Workers Protest Against Using Skull and Crossbones Sign on Packets 2
(Date:7/22/2008)...y and Efficacy of Treating Patients with ...CO, and YONGIN-SI, South Korea, July 22 /PRNewswir..., Ontario), and its South,Korean partner Green Cro...,a Phase I clinical trial of its first-in-class le...s well-tolerated and resulted in clear,anti-cancer...
(Date:7/22/2008)...(R) and Apidra(R) Resulted in Significant, Reducti...ver the Algorithm ... Results from the "Adjust to,Target in Type 2 Diab...rate,Counting for Adjustment of Mealtime Insulin G...abetes Association,s (ADA) medical journal,Diabet...
(Date:7/22/2008)... July 22 /- Hyperion,Therapeutics, In...nrollment,in its Phase 1/2 clinical trial to evalu...g effects of HPN-100 (formally called GT4P) versus...ith urea cycle disorders,(UCD). The company plans ...,of this year., (Logo: http://www.newscom.com/cg...
(Date:7/22/2008)...Columbia University Medical Center Based on ...ogy, The Test Differentiates Squamous From Non-S...ifying Squamous-Cell Carcinoma of the Lung With ...90 Percent,This is the First CLIA Approved Test Wh...iomarkers for Accurate Diagnosis of Lung Cancer, ...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 1NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 2NBTY to Webcast Presentation at Bank of America Consumer Conference 3A Announces Preliminary Sales and the Repurchase of 6 1 Million Shares 13854 3Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 1Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference 3809 2More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 1More than Seventy Percent of Top US Hospitals Control Patient Temperature with High Tech Arctic Sun 28TM 29 13849 2AVMA 3A Keep Pets Safe This Easter 13847 1AVMA 3A Keep Pets Safe This Easter 13847 2
...w Dissociation from HCV,Protease , ,WASHINGTON, Ma...etwork/ -- InterMune, Inc. (Nasdaq: ITMN) today pr...titis C virus (HCV) NS3/4A,protease inhibitor, ITM...e Disease Week (DDW) meeting being held May 19-24 ...ct #M1816) examined,ITMN-191 potency and binding k...
... FDA for long-term maintenance,treatment of COPD b...ed formoterol fumarate provides improved lung func... patient quality of,life, and positive safety prof... Data presented at the,International Conference of...hat Perforomist (formoterol fumarate) Inhalation,S...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: